Actually, the 8-K filed on March 20, 2014 states the following:
On March 20, 2014, The PAWS Pet Company Inc. (the “Company”) entered into an Agreement and Plan of Merger Agreement (the “APMA”) with Pharmacy Development Corp., a California corporation (“PDC”) whereby, subject to closing requirements, the Company shall acquire PDC through a forward triangular merger into the Company’s wholly owned subsidiary PDC, INC., a Nevada corporation. Upon the closing of the merger, the Company shall issue 500,000 shares of Series D Preferred Stock to the shareholders of PDC and assume certain convertible notes of PDC. Barring any unforeseen circumstances and/or events to the contrary, the parties will close the merger prior to or on March 31, 2014.